Treatment of protozoal infection with bacitracin

Details Treatment of protozoal infection with bacitracin Treatment of protozoal infection with bacitracin

A - Human Necessities

61

K

A61K 38/12 (2006.01)

Patent

CA 2122598

Protozoal infection of human beings or animals is treated with a divalent metal salt of bacitracin. Some infectious agents sensitive to such treatment include human pathogens such as Entamoeba histolytica, Trichomonas vaginalir, Giardia lamblia, Cryptosporidium parvum, and animal pathogens such as Tritrichomonas foetus and Tritrichomonas gallinae.

On traite les infections à protozoaires chez l'homme ou chez un animal, à l'aide d'un sel métallique divalent de bacitracine. Les agents infectieux sensibles à ce traitement sont notamment les agents pathogènes humains tels que Entamoeba histolytica, Trichomonas vaginalis, Giarda lamblia, et Cryptosporidium parvum, et les agents pathogènes animaux tels que Tritrichomonas foetus et Tritrichomonas gallinae.

Affiliated with

Also associated with

Rating

Treatment of protozoal infection with bacitracin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of protozoal infection with bacitracin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of protozoal infection with bacitracin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1606832